TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam
- PMID: 29941651
- PMCID: PMC6125571
- DOI: 10.1128/AAC.00688-18
TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam
Abstract
TEM-184, a novel TEM-derived extended-spectrum β-lactamase (ESBL), was isolated from an Escherichia coli ST354 clinical strain. Compared to TEM-1, TEM-184 contains the mutations Q6K, E104K, I127V, R164S, and M182T. Kinetic analysis of this enzyme revealed extended-spectrum activity against aztreonam in particular. TEM-184 was also susceptible to inhibitors, including clavulanic acid, tazobactam, and avibactam.
Keywords: ESBL; avibactam; inhibitors.
Copyright © 2018 American Society for Microbiology.
Figures

References
-
- Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob Agents Chemother 38:761–766. doi:10.1128/AAC.38.4.761. - DOI - PMC - PubMed
-
- European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2016. EUCAST guideline for the detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance, version 2.0, 2016. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_m....
-
- Aung MS, San N, Maw WW, San T, Urushibara N, Kawaguchiya M, Sumi A, Kobayashi N. 2018. Prevalence of extended-spectrum ß-lactamase and carbapenemase genes in clinical isolates of Escherichia coli in Myanmar: dominance of blaNDM-5 and emergence of blaOXA-181. Microb Drug Resist. doi:10.1089/mdr.2017.0387. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous